Part 5 - PRESCRIPTION DRUGS
- Section 25.5-5-500.3 - Authorization to bill third party
- Section 25.5-5-501 - Providers - drug reimbursement
- Section 25.5-5-502 - Unused medications - reuse - rules - definition
- Section 25.5-5-503 - Prescription drug benefits - authorization - dual-eligible participation
- Section 25.5-5-504 - Providers of pharmaceutical services
- Section 25.5-5-505 - Prescribed drugs - mail order - rules
- Section 25.5-5-506 - Prescribed drugs - utilization review
- Section 25.5-5-507 - Prescription drug information and technical assistance program - rules
- Section 25.5-5-508 - [Repealed]
- Section 25.5-5-509 - Substance use disorder - prescription drugs - opioid antagonist - definition
- Section 25.5-5-510 - Pharmacy reimbursement - substance use disorder - injections
- Section 25.5-5-511 - Reimbursement for pharmacists' services - legislative declaration
- Section 25.5-5-512 - Pharmacy benefit - mental health and substance use disorders - legislative declaration
- Section 25.5-5-512.5 - Medications for opioid use disorder - pharmacists - reimbursement - definition
- Section 25.5-5-513 - Pharmacy benefits - prescription drugs - rebates - analysis
- Section 25.5-5-514 - Prescription drugs used for treatment or prevention of HIV - prohibition on utilization management - definition
- Section 25.5-5-515 - Pharmacy reimbursement - vaccine administration to children - legislative declaration
- Section 25.5-5-516 - Serious mental illness - prescribed drugs
- Section 25.5-5-517 - Prescription drugs for treating mental health disorders or conditions - prior authorization - rules - definitions
- Section 25.5-5-518 - Coverage for choline dietary supplements - rules